• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Akido Appoints Eric Chin as its first Chief Financial Officer As the Company Prepares to Accelerate Growth

    1/31/23 9:30:00 AM ET
    $AMEH
    Professional Services
    Consumer Discretionary
    Get the next $AMEH alert in real time by email

    LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Akido, a tech-integrated medical network reimagining healthcare from the ground up, announced that Eric Chin has been appointed Chief Financial Officer, effective immediately. Chin will work closely with Akido's co-founders as the company continues to bring its unique blend of AI-powered technology, best-in-class medical services and scalable preventive care programs to new markets across the U.S. Previously, Chin served as Chief Financial Officer at Apollo Medical Holdings (ApolloMed), a publicly traded physician-centric technology-powered healthcare company (NASDAQ:AMEH) that increased reported total revenue from approximately $520 million in 2018 to approximately $774 million in 2021. During Chin's time at ApolloMed, the company was a member of the S&P SmallCap 600.

    "Our focus on social determinants of health and our expertise in both technology and medical care are unparalleled and we believe we are on the precipice of driving much-needed change in how the health system cares for our most vulnerable," said Prashant Samant, co-founder and CEO of Akido. "Eric has a proven track record of accelerating growth at his previous companies. His impressive knowledge of the financial side of healthcare paired with his passion for helping those in need makes him the perfect partner to help us drive exponential growth for Akido as we continue to expand our medical network and ‘whole person' care philosophy across the country."

    In his new role as CFO for Akido, Eric Chin will oversee all finance and accounting operations, including participation in fundraising and investor relations. During his time as CFO of ApolloMed, Chin's keen financial acumen was instrumental in developing the company's internal financial controls and spearheading its capital allocation, corporate finance and communications strategies. In addition to his role as CFO, Chin held a number of financial and operational leadership positions at ApolloMed and its subsidiaries, including Interim Co-Chief Operating Officer and Corporate Secretary. Chin has also previously held leadership roles at Public Storage within its real estate division, and Alexandria Real Estate Equities, both of which are publicly traded and members of the S&P 500. Chin began his career at Ernst & Young, LLP, and is a Certified Public Accountant and a Certified Healthcare Financial Professional. He received his Bachelor of Arts in Business/Economics with Accounting and Computing from UCLA.

    Added Chin, "As an Angeleno, I see the need for change in our city everyday. Our country's healthcare system is clearly neglecting our most vulnerable citizens and I am honored to be joining Akido, a company that has dedicated itself to driving this necessary change. I look forward to helping the growth of the company as it spreads its care model nationwide."

                                    

    To learn more about Akido, please visit https://www.akidolabs.com/.

                                            

    About Akido:                                

    Akido is rebuilding the healthcare experience from the ground up, focusing on addressing the systemic inequities that lead to chronic illness and vulnerability. Through early interventions designed around social determinants of health (SDoH), best-in-class care and human-centered technology, Akido is building a healthcare model that allows for all patients to live their fullest lives. Founded in 2015, Akido was created out of the University of Southern California's D-Health Lab with the idea that empowering government, healthcare, and nonprofit services with population-based data could help usher in a new era of preventive public health. Today, Akido is building a full stack medical network that leverages its predictive capabilities to provide a frictionless experience for patients and care providers. Akido's proprietary Wellness Graph – one of the country's most powerful platforms for predicting health and social outcomes – enables the company to identify key markers on a patient's journey into chronic illness and build preventive programs to address them. Akido's medical network currently covers more than 250,000 patients. For more information, visit https://www.akidolabs.com/.

    Media Contact:

    Sharna Daduk

    Head of Communications, Akido Labs

    [email protected]



    Primary Logo

    Get the next $AMEH alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $AMEH

    DatePrice TargetRatingAnalyst
    2/22/2024$44.00 → $55.00Neutral → Buy
    BofA Securities
    1/24/2024$45.00Buy
    Stifel
    12/22/2023$41.00Hold
    Truist
    10/17/2023$45.00Buy
    BTIG Research
    4/12/2023$44.00Neutral
    BofA Securities
    12/19/2022$40.00Buy
    Lake Street
    9/21/2022Outperform
    William Blair
    1/11/2022$93.00Buy
    Colliers Securities
    More analyst ratings

    $AMEH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Apollo Medical upgraded by BofA Securities with a new price target

      BofA Securities upgraded Apollo Medical from Neutral to Buy and set a new price target of $55.00 from $44.00 previously

      2/22/24 9:10:05 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Stifel initiated coverage on Apollo Medical with a new price target

      Stifel initiated coverage of Apollo Medical with a rating of Buy and set a new price target of $45.00

      1/24/24 6:57:05 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Truist initiated coverage on Apollo Medical with a new price target

      Truist initiated coverage of Apollo Medical with a rating of Hold and set a new price target of $41.00

      12/22/23 7:19:49 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Apollo Medical Holdings, Inc. Becomes Astrana Health, Inc.

      ALHAMBRA, Calif., Feb. 22, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, announced today it will formally change its name from Apollo Medical Holdings, Inc. ("ApolloMed") to Astrana Health, Inc. ("Astrana Health"). As previously announced, the Company will begin trading under the ticker symbol "ASTH." Both changes will take effect February 26, 2024.

      2/22/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

      ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      1/31/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

      ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra

      1/29/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Kumar Dinesh M. was granted 150,395 shares (SEC Form 4)

      4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      1/24/24 4:31:15 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form 3 filed by new insider Kumar Dinesh M.

      3 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      1/24/24 4:30:18 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Vong John was granted 14,352 shares, increasing direct ownership by 293% to 19,253 units (SEC Form 4)

      4 - Apollo Medical Holdings, Inc. (0001083446) (Issuer)

      12/19/23 9:10:18 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    SEC Filings

    See more
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/29/24 6:03:30 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/27/24 4:19:15 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      2/26/24 6:04:01 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Leadership Updates

    Live Leadership Updates

    See more
    • ApolloMed and BASS Medical Group to Forge a Value-Based Healthcare Partnership

      ALHAMBRA, Calif., Jan. 29, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc.("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced a strategic long-term partnership with BASS Medical Group, one of the largest multi-specialty medical groups in the Greater San Francisco Bay Area. The partnership will bolster BASS Medical Group's value-based care and operational infra

      1/29/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Akido Appoints Eric Chin as its first Chief Financial Officer As the Company Prepares to Accelerate Growth

      LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Akido, a tech-integrated medical network reimagining healthcare from the ground up, announced that Eric Chin has been appointed Chief Financial Officer, effective immediately. Chin will work closely with Akido's co-founders as the company continues to bring its unique blend of AI-powered technology, best-in-class medical services and scalable preventive care programs to new markets across the U.S. Previously, Chin served as Chief Financial Officer at Apollo Medical Holdings (ApolloMed), a publicly traded physician-centric technology-powered healthcare company (NASDAQ:AMEH) that increased reported total revenue from approximately $520 million i

      1/31/23 9:30:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • The Oncology Institute Names Mihir Shah as Chief Financial Officer

      CERRITOS, Calif., April 04, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute of Hope and Innovation (NASDAQ:TOI) today announced the appointment of Mihir Shah as chief financial officer, effective immediately. In this role, Mr. Shah will lead the Accounting, Finance, Revenue Cycle Management, and Investor Relations functions, playing a key role in driving TOI's public company success and executing the strategic growth plan. Mr. Shah succeeds Scott Dalgleish, who will serve as a senior advisor through a transition period. Mr. Shah joins TOI with fifteen years of industry leadership experience across public, private, and not-for-profit organizations. Most recently Mr. Shah served as chief fi

      4/4/22 6:01:00 AM ET
      $AMEH
      $TOI
      Professional Services
      Consumer Discretionary
      Medical/Nursing Services
      Health Care

    $AMEH
    Financials

    Live finance-specific insights

    See more
    • Apollo Medical Holdings, Inc. Schedules 2023 Fourth Quarter and Full Year Financial Results Release and Conference Call

      ALHAMBRA, Calif., Jan. 31, 2024 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and full year ended December 31, 2023, after the close of the stock market on Tuesday, February 27, 2024. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      1/31/24 8:00:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Reports Second Quarter 2023 Results

      Company to Host Conference Call on Monday, August 7, 2023, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Aug. 7, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced its consolidated financial results for the second quarter ended June 30, 2023. Brandon Sim, Co-Chief Executive Officer of ApolloMed, stated, "Our strong

      8/7/23 5:17:00 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • Apollo Medical Holdings, Inc. Schedules 2023 Second Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., July 28, 2023 /PRNewswire/ -- Apollo Medical Holdings, Inc. ("ApolloMed," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:AMEH), a leading physician-centric, technology-powered healthcare company focused on enabling providers in the successful delivery of value-based care, today announced that it will release financial results for the second quarter ended June 30, 2023, after the close of the stock market on Monday, August 7, 2023. The Company will discuss those results in a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      7/28/23 8:05:00 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary

    $AMEH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      2/13/24 4:58:57 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13D/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13D/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      11/17/23 4:15:14 PM ET
      $AMEH
      Professional Services
      Consumer Discretionary
    • SEC Form SC 13G/A filed by Apollo Medical Holdings Inc. (Amendment)

      SC 13G/A - Apollo Medical Holdings, Inc. (0001083446) (Subject)

      2/9/23 11:07:39 AM ET
      $AMEH
      Professional Services
      Consumer Discretionary